BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO

Reuters03:12
BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO

** Shares of hair-restoration drug developer Veradermics MANE.N more than double in New York Stock Exchange debut

** Stock opened for trading at $34 and rose as high as $40; last up 126.5% at $38.5

** MANE sold 15.1 million shares in an upsized IPO at $17 apiece to raise $256.3 million

** It had earlier planned on selling 13.35 million shares priced between $14 and $16 apiece

** MANE is developing treatments for pattern hair loss, a condition affecting roughly 50 million men and 30 million women in the United States

** Pharma giant Eli Lilly LLY.N had indicated interest in buying up to 4.9% of MANE shares sold in the IPO

** Jefferies, Leerink Partners, Citigroup, and Cantor were joint book-running managers for offering

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment